A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint
- 20 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 68 (3) , 922-932
Abstract
Summary The literature on potential outcomes has shown that traditional methods for characterizing surrogate endpoints in clinical trials based only on observed quantities can fail to capture causal relationships between treatments, surrogates, and outcomes. Building on the potential‐outcomes formulation of a principal surrogate, we introduce a Bayesian method to estimate the causal effect predictiveness (CEP) surface and quantify a candidate surrogate’s utility for reliably predicting clinical outcomes. In considering the full joint distribution of all potentially observable quantities, our Bayesian approach has the following features. First, our approach illuminates implicit assumptions embedded in previously‐used estimation strategies that have been shown to result in poor performance. Second, our approach provides tools for making explicit and scientifically‐interpretable assumptions regarding associations about which observed data are not informative. Through simulations based on an HIV vaccine trial, we found that the Bayesian approach can produce estimates of the CEP surface with improved performance compared to previous methods. Third, our approach can extend principal‐surrogate estimation beyond the previously considered setting of a vaccine trial where the candidate surrogate is constant in one arm of the study. We illustrate this extension through an application to an AIDS therapy trial where the candidate surrogate varies in both treatment arms.Keywords
This publication has 19 references indexed in Scilit:
- Interval Estimation for Messy Observational DataStatistical Science, 2009
- Evaluating Candidate Principal Surrogate EndpointsBiometrics, 2008
- Evaluating a surrogate endpoint at three levels, with application to vaccine developmentStatistics in Medicine, 2008
- Principal Stratification for Causal Inference With Extended Partial ComplianceJournal of the American Statistical Association, 2008
- Criteria for Surrogate End PointsJournal of the Royal Statistical Society Series B: Statistical Methodology, 2007
- Augmented Designs to Assess Immune Response in Vaccine TrialsBiometrics, 2006
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Inference from Iterative Simulation Using Multiple SequencesStatistical Science, 1992
- Sampling-Based Approaches to Calculating Marginal DensitiesJournal of the American Statistical Association, 1990
- Analysis of Covariance: Its Nature and UsesBiometrics, 1957